No mutation detected in five hot spot codons of the TP53 gene by restriction site mutation analysis in patients with carcinoma of the tongue

International Journal of Biological Markers

Volumn 25, Issue 1, 2010, Pages 46-51

  Vora, Hemangini H ^a   Mehta, Shalvi V ^a   Shukla, Shilin N ^a   Shah, Pankaj M ^a  

^a GUJARAT CANCER AND RESEARCH INSTITUTE   (India)

Author keywords

Restriction site mutation analysis; Tongue cancer; TP53 mutation

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CARCINOGENESIS; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; EXON; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUTATIONAL ANALYSIS; ORAL SURGERY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RESTRICTION SITE; SMOKELESS TOBACCO; TONGUE CARCINOMA;

NICOTIANA TABACUM;

EID: 77950999622     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460081002500107     Document Type: Article

References (45)

1. Levine A. P53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-331
2. Hollstein M, Rice K, Greenblatt MS, et al. Database of p53 somatic mutations in human tumors and cell lines. Nucl Acids Res 1994; 22: 3551-3555 (Pubitemid 24299821)
3. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-4878 (Pubitemid 24289415)
4. Raybaud-Diogène H, Tétu B, Morency R, Fortin A, Monteil RA. p53 over-expression in head-and-neck squamous-cell carcinomas: review of the literature. Eur J Cancer B Oral Oncol 1996; 32B: 143-149
5. Szymañska K, Hainaut P. TP53 and mutations in human cancer. Acta Biochim Pol 2003; 50: 231-238
6. Lazarus P, Stern J, Zwiebel N, et al. Relationship between p53 mutation incidence in oral cavity squamous cell carcinomas and patient tobacco use. Carcinogenesis 1996; 17: 733-739 (Pubitemid 26129686)
7. Somers KD, Merrick MA, Lopez ME, et al. Frequent p53 mutations in head and neck cancer. Cancer Res 1992; 52: 5997-6000.
8. Cruz I, Snijders PJF, Houten VV, et al. Specific p53 immunostaining patterns are associated with smoking habits in patients with oral squamous cell carcinomas. J Clin Pathol 2002; 55: 834-840 (Pubitemid 35316250)
9. Wong YK, Liu TY, Chang KW, et al. p53 alterations in betel quid- and tobacco-associated oral squamous cell carcinomas from Taiwan. J Oral Pathol Med 1998; 27: 243-248
10. Acha-Sagredo A, Ruesga MT, Rodriguez C, et al. p53 mutation is rare in oral mucosa brushings from patients previously treated for a head and neck squamous cell carcinoma. Oral Oncol 2009; 45: 661-664
11. Ralhan R, Agarwal S, Nath N, et al. Correlation between p53 gene mutations and circulating antibodies in betel-and tobacco-consuming North Indian population. Oral Oncology 2001; 37: 243-250 (Pubitemid 32245848)
12. Ranasinghe A, MacGeoch C, Dyer S, et al. Some oral carcinomas from Sri Lankan betel/tobacco chewers overexpress p53 oncoprotein but lack mutations in exons 5-9. Anticancer Res 1993; 13: 2065-2068 (Pubitemid 24036327)
13. Thomas S, Brennan J, Martel G, et al. Mutations in the conserved regions of p53 are infrequent in betel-associated oral cancers from Papua New Guinea. Cancer Res 1994; 54: 3588-3593 (Pubitemid 24225988)
14. Barten M, Ostwald C, Milde-Langosch K, et al. HPV DNA and p53 alterations in oropharyngeal carcinomas. Virchows Arch 1995; 427: 153-157
15. Xu J, Gimenez-Conti IB, Cunningham JE, et al. Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. Cancer 1998; 83: 204-212 (Pubitemid 28317798)
16. Mineta H, Borg A, Dictor M, et al. p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma. Br J Cancer 1998; 78: 1084-1090 (Pubitemid 28463987)
17. Kuo MY, Huang JS, Hsu HC, et al. Infrequent p53 mutations in patients with areca quid chewing-associated oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 1999; 28: 221-225
18. Saranath D, Tandle AT, Teni TR, et al. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India. Oral Oncol 1999; 35: 242-250 (Pubitemid 29148356)
19. Hogmo A, Borresen-Dale AL, Blegen H, et al. TP53 mutations do not correlate with locoregional recurrence in stage I tongue carcinomas. Anticancer Res 1999; 19: 3433-3438 (Pubitemid 30000199)
20. Ganly I, Soutar DS, Brown R, Kaye SB. P53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy. Br J Cancer 2000; 82: 392-398 (Pubitemid 30045387)
21. Ogmundsdottir HM, Bjornsson J, Holbrook WP. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients. J Oral Pathol Med 2009; 38: 565-571
22. Smardova J, Ksicova K, Binkova H, et al. Analysis of tumor suppressor p53 status in head and neck squamous cell carcinoma. Oncol Rep 2004; 11: 923-929
23. Field JK, Spandidos DA, Malliri A, et al. Elevated p53 expression correlates with a history of heavy smoking in squamous-cell carcinoma of the head and neck. Br J Cancer 1991; 64: 573-577
24. Field JK, Zoumpourlis V, Spandidos DA, Jones AS. p53 expression and mutations in squamous-cell carcinoma of the head and neck: expression correlates with the patient's use of tobacco and alcohol. Cancer Detect Prev 1994; 18: 197-208. (Pubitemid 2098798)
25. Brennan JA, Boyle JO, Koch WM, et al. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 1995; 332: 712-717
26. Lazarus P, Idris AM, Kim J, Calcagnotto A, Hoffmann D. p53 mutations in head-and-neck squamous-cell carcinomas from Sudanese snuff (toombak) users. Cancer Detect Prev 1996; 20: 270-278 (Pubitemid 26311794)
27. Kaur J, Srivastava A, Ralhan R. Over-expression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India. Int J Cancer 1994; 58: 340-345 (Pubitemid 24254640)
28. Vora HH, Trivedi TI, Shah NG, et al. p53 expression in leukoplakia and carcinoma of the tongue. Int J Biol Markers 2006; 21: 74-80. (Pubitemid 44210035)
29. Jenkins GJS, Doak SH, Griffiths AP, et al. Early p53 mutations in non-dysplastic Barrett's tissue detected by the restriction site mutation (RSM) methodology. Br J Cancer 2003; 88: 1271-1276
30. Jenkins GJS, Williams GL, Beynon J, et al. Restriction enzymes: a molecular tool for analysing the genetic alterations in cancer progression. Br J Surg 2001; 89: 8-20.
31. Jenkins GJS, Morgan C, Parry EM, et al. The detection of mutations induced in vitro in the human p53 gene by hydrogen peroxide with the restriction site mutation (RSM) assay. Mutat Res 2001; 498: 135-144 (Pubitemid 32973669)
32. UICC. TNM classification of malignant tumors. UICC Technical Report Series, Geneva: UICC 1980; 5: 2.
33. Pillai G, Roberts H, Gatter K, Pezzella F. p53 expression in normal paraffin-embedded tissue using different antibodies and antigen retrieval buffer systems. Histopathology 2003; 42: 83-87 (Pubitemid 36062572)
34. Battifora H. p53 immunohistochemistry: a word of caution. Hum Pathol 1994, 25: 435-437
35. Coggi G, Bosari S, Ronacalli M, et al. P53 protein accumulation and p53 gene mutation in esophageal carcinoma. Cancer 1997; 79: 425-432
36. Munirajan AK, Tutsumi-Ishii Y, Mohanprasad BKC, et al. p53 gene mutations in oral carcinomas from India. Int J Cancer 1996; 66: 297-300. (Pubitemid 26163605)
37. Sakai E, Rikimaru K, Ueda M, et al. The p53 tumor suppressor gene and ras oncogene mutations in oral squamous cell carcinoma. Int J Cancer 1992; 52: 867-872 (Pubitemid 23009500)
38. Atula S, Kurvinen K, Grenman R, et al. SSCP pattern indicative for p53 mutation is related to advanced stage and high-grade of tongue cancer. Eur J Cancer B Oral Oncol 1996; 32B: 222-229 (Pubitemid 126659000)
39. Ahomadegbe JC, Barrois M, Fogel S, et al. High incidence of p53 alterations in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene 1995; 10: 1217-1227
40. Patnaik S, Nayak BK, Das BR. Genetic alteration of p53 in oral tumors. In: Varma AK, ed. Oral oncology, Vol. VI. New Delhi, India: Macmillan India Limited, 1999; 87-92.
41. Tsurusako SI, Tanaka H, Hayashi Y, et al. Low incidence of p53 mutations in well-differentiated tongue squamous cell carcinoma in Japan. Jap J Clin Oncol 2002; 32: 327-331 (Pubitemid 43102784)
42. Soussi T, Kato S, Levy PP, Ishioka C. Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations. Hum Mutat 2005; 25: 6-17. (Pubitemid 40075908)
43. Poeta ML, Manola J, Goldwasser MA, et al. TP53 mutations and survival in squamous cell carcinoma of the head and neck. N Engl J Med 2007; 357: 2552-2561 (Pubitemid 350294222)
44. Ku TK, Nguyen DC, Karaman M, Gill P, Hacia JG, Crowe DL. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer. Mol Cancer Res 2007; 5: 351-362 (Pubitemid 46706997)
45. Offner S, Schmaus W, Witter K, et al. p53 gene mutations are not required for early dissemination of cancer cells. Proc Natl Acad Sci U S A 1999; 96: 6942-6946 (Pubitemid 29274989)